COM:AGILONHEALTH
agilon health
- Stock
Last Close
1.78
22/11 21:00
Market Cap
2.32B
Beta: -
Volume Today
2.78M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
---|---|---|---|---|---|---|
average inventory | 5.30M - | 5.30M 0% | ||||
average payables | 224.19M - | 306.04M 36.51% | 441.03M 44.11% | 265.05M 39.90% | ||
average receivables | 118.90M - | 218.98M 84.17% | 395.49M 80.60% | 720.02M 82.06% | ||
book value per share | -0.60 - | -0.74 22.45% | 2.93 495.73% | 2.55 12.87% | 1.62 36.55% | |
capex per share | -0.01 - | -0.01 39.96% | -0.04 489.56% | -0.08 122.27% | -0.04 51.62% | |
capex to depreciation | -0.09 - | -0.17 76.72% | -0.92 449.08% | -2.37 159.13% | -0.79 66.89% | |
capex to operating cash flow | 0.04 - | 0.04 17.45% | 0.09 105.16% | 0.25 175.53% | 0.10 59.41% | |
capex to revenue | -0.00 - | -0.00 60.77% | -0.01 279.62% | -0.01 64.70% | -0.00 69.59% | |
cash per share | 0.32 - | 0.28 13.80% | 2.79 904.95% | 2.23 20.14% | 1.19 46.38% | |
days of inventory on hand | 1.49 - | |||||
days payables outstanding | 89.72 - | 84.45 5.87% | 73.11 13.43% | 74.53 1.95% | ||
days sales outstanding | 42.85 - | 43.31 1.08% | 58.41 34.87% | 67.06 14.82% | 79.70 18.84% | |
debt to assets | 0.19 - | 0.16 15.21% | 0.03 81.40% | 0.03 16.05% | 0.02 13.53% | |
debt to equity | -0.34 - | -0.26 23.43% | 0.04 117.24% | 0.04 5.79% | 0.06 39.51% | |
dividend yield | ||||||
earnings yield | -0.01 - | -0.01 44.89% | -0.04 660.06% | -0.02 59.72% | -0.05 215.68% | |
enterprise value | 11.86B - | 11.90B 0.32% | 9.08B 23.70% | 6.13B 32.43% | 5.06B 17.46% | |
enterprise value over ebitda | -184.70 - | -296.60 60.58% | -23.65 92.03% | -63.60 168.90% | -19.92 68.69% | |
ev to operating cash flow | -114.18 - | -223.60 95.83% | -61.27 72.60% | -46.89 23.46% | -32.41 30.88% | |
ev to sales | 14.93 - | 9.76 34.59% | 4.95 49.30% | 2.26 54.25% | 1.17 48.21% | |
free cash flow per share | -0.28 - | -0.14 48.56% | -0.43 200.15% | -0.40 7.56% | -0.42 5.04% | |
free cash flow yield | -0.01 - | -0.00 48.56% | -0.02 244.61% | -0.02 54.63% | -0.03 35.09% | |
graham net net | -1.15 - | -1.34 16.67% | 2.05 253.11% | 1.54 24.73% | 0.28 81.74% | |
graham number | 2.01 - | 1.65 17.85% | 8.46 411.83% | 3.88 54.19% | 4.84 24.79% | |
income quality | 0.37 - | 0.89 141.19% | 0.36 58.89% | 1.22 236.08% | 0.59 51.44% | |
intangibles to total assets | 0.28 - | 0.23 18.31% | 0.06 73.26% | 0.06 5.29% | 0.05 21.52% | |
interest coverage | -11.75 - | -6.97 40.72% | -64.10 820.09% | 24.36 138.00% | 34.87 43.14% | |
interest debt per share | 0.23 - | 0.21 6.68% | 0.15 30.81% | 0.10 34.74% | 0.08 18.27% | |
inventory turnover | 244.67 - | |||||
invested capital | -0.34 - | -0.26 23.43% | 0.04 117.24% | 0.04 5.79% | 0.06 39.51% | |
market cap | 11.90B - | 11.93B 0.21% | 10.07B 15.60% | 6.59B 34.58% | 5.13B 22.10% | |
net current asset value | -389.29M - | -436.89M 12.23% | 872.54M 299.71% | 794.41M 8.95% | 400.23M 49.62% | |
net debt to ebitda | 0.71 - | 0.84 17.60% | 2.58 208.61% | 4.70 82.02% | 0.27 94.23% | |
net income per share | -0.30 - | -0.16 44.89% | -1.09 561.99% | -0.26 75.92% | -0.64 145.46% | |
operating cash flow per share | -0.27 - | -0.14 48.88% | -0.40 187.36% | -0.32 19.33% | -0.38 19.19% | |
payables turnover | 4.07 - | 4.32 6.23% | 4.99 15.51% | 4.90 1.91% | ||
receivables turnover | 8.52 - | 8.43 1.06% | 6.25 25.85% | 5.44 12.90% | 4.58 15.85% | |
research and ddevelopement to revenue | ||||||
return on tangible assets | -0.39 - | -0.18 53.47% | -0.27 48.33% | -0.07 75.29% | -0.16 136.29% | |
revenue per share | 2.07 - | 3.17 53.04% | 4.92 55.30% | 6.64 34.96% | 10.56 59.08% | |
roe | 0.49 - | 0.22 55.00% | -0.37 267.28% | -0.10 72.36% | -0.40 286.89% | |
roic | 0.73 - | 0.28 61.62% | -0.34 223.28% | -0.10 70.39% | -0.33 224.22% | |
sales general and administrative to revenue | 0.15 - | 0.11 27.12% | 0.25 120.61% | 0.08 67.48% | 0.07 18.11% | |
shareholders equity per share | -0.60 - | -0.74 22.45% | 2.93 495.73% | 2.55 12.87% | 1.62 36.55% | |
stock based compensation to revenue | 0.01 - | 0.01 16.54% | 0.16 2,804.98% | 0.01 93.43% | 0.02 53.64% | |
tangible asset value | -344.71M - | -386.74M 12.19% | 994.66M 357.19% | 931.39M 6.36% | 573.12M 38.47% | |
tangible book value per share | -0.90 - | -1.00 11.95% | 2.67 365.40% | 2.28 14.44% | 1.40 38.58% | |
working capital | 45.92M - | 27.36M 40.41% | 1.01B 3,592.11% | 916.18M 9.31% | 502.92M 45.11% |
All numbers in USD (except ratios and percentages)